VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...
Issued on behalf of Oncolytics Biotech Inc.USANewsGroup.com News CommentaryVANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- The precision oncology market ...
This case presents an infant male child who initially presented with clinical features resembling glycogen storage disease type I (GSD I), including hepatomegaly, a doll-like face and metabolic ...
Blood cancer is an umbrella term for a variety of diseases that affect the blood, bone marrow and lymphatic system. Like most ...
This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...
Which genes are required for turning embryonic stem cells into brain cells, and what happens when this process goes wrong? In ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
Researchers found a genetic variant that appears to protect against the development of CHIP, a phenomenon that can lead to ...
A recent study finds that certain psychiatric disorders have considerable genetic overlap. But these genes aren’t the whole ...
News Medical on MSN
Inheritable genetic variant offers protection against blood cancer risk and progression
A newly identified and rare genetic variant slows the growth of mutated blood stem cells, researchers report, and it reduces the risk of leukemia. The findings offer insight into why some people are ...
Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback